Personal tools

CL:0000988

From FANTOM5_SSTAR

Jump to: navigation, search
Name:hematopoietic cell
Namespace:FANTOM
Definition:"A cell of a hematopoietic lineage." [GO_REF:0000031, GOC:add]
Xrefs:
links:

BTO:0000574
FMA:70366

FMA:83598
Synonyms: "haematopoietic cell" EXACT []
"haemopoietic cell" EXACT []
"hemopoietic cell" EXACT []


Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:CL:0000548(animal cell),CL:0002371(somatic cell)



Children


is a:CL:0000080 (circulating cell),CL:0000081 (blood cell),CL:0000738 (leukocyte),CL:0000763 (myeloid cell),CL:0008001 (hematopoietic precursor cell),CL:1001610 (bone marrow hematopoietic cell)
derives from:FF:0101035 (hematopoietic cell line sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)


FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.


Human (Homo sapiens)

  • 10399-106A3 (acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh))
  • 10400-106A4 (acute myeloid leukemia (FAB M5) cell line:THP-1 (revived))
  • 10405-106A9 (acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed))
  • 10409-106B4 (chronic myelogenous leukemia cell line:KU812)
  • 10416-106C2 (chronic lymphocytic leukemia (T-CLL) cell line:SKW-3)
  • 10421-106C7 (adult T-cell leukemia cell line:ATN-1)
  • 10422-106C8 (Burkitt's lymphoma cell line:DAUDI)
  • 10427-106D4 (b cell line:RPMI1788)
  • 10429-106D6 (acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL)
  • 10435-106E3 (Hodgkin's lymphoma cell line:HD-Mar2)

... further results Mouse (Mus musculus)

  • 10399-106A3 (acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh))
  • 10400-106A4 (acute myeloid leukemia (FAB M5) cell line:THP-1 (revived))
  • 10405-106A9 (acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed))
  • 10409-106B4 (chronic myelogenous leukemia cell line:KU812)
  • 10416-106C2 (chronic lymphocytic leukemia (T-CLL) cell line:SKW-3)
  • 10421-106C7 (adult T-cell leukemia cell line:ATN-1)
  • 10422-106C8 (Burkitt's lymphoma cell line:DAUDI)
  • 10427-106D4 (b cell line:RPMI1788)
  • 10429-106D6 (acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL)
  • 10435-106E3 (Hodgkin's lymphoma cell line:HD-Mar2)

... further results


Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000988 (hematopoietic cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
8.14e-116FFCP PHASE1:Hg19::chr1:206730535..206730549,+#_c24c61fec9696544da3c550217168898p4@RASSF5
8.14e-116FFCP PHASE2:Hg19::chr1:206730535..206730549,+#_c24c61fec9696544da3c550217168898p4@RASSF5
1.31e-113FFCP PHASE2:Hg19::chr2:68592394..68592405,+#_957aae33a365bb57c85c04a960c12127p2@PLEK
1.31e-113FFCP PHASE1:Hg19::chr2:68592394..68592405,+#_957aae33a365bb57c85c04a960c12127p2@PLEK
3.18e-110FFCP PHASE1:Hg19::chr7:50344251..50344288,+#_2b84a62f16431f924f9e2d9c9047d242p3@IKZF1
3.18e-110FFCP PHASE2:Hg19::chr7:50344251..50344288,+#_2b84a62f16431f924f9e2d9c9047d242p3@IKZF1
5.7e-109FFCP PHASE1:Hg19::chr5:169724839..169724855,-#_d750ad97ea37a6cbb9d4c799512a0f38p3@LCP2
5.7e-109FFCP PHASE2:Hg19::chr5:169724839..169724855,-#_d750ad97ea37a6cbb9d4c799512a0f38p3@LCP2
1.37e-104FFCP PHASE1:Hg19::chr2:143886927..143886938,+#_71a944731b80e78e46a3b094ae596cefp3@ARHGAP15
1.37e-104FFCP PHASE2:Hg19::chr2:143886927..143886938,+#_71a944731b80e78e46a3b094ae596cefp3@ARHGAP15
6.01e-104FFCP PHASE1:Hg19::chr2:144021511..144021516,+#_2782b2983ae33ff167a1ca33170203a7p@chr2:144021511..144021516, +
6.01e-104FFCP PHASE2:Hg19::chr2:144021511..144021516,+#_2782b2983ae33ff167a1ca33170203a7p@chr2:144021511..144021516, +
1.09e-103FFCP PHASE2:Hg19::chr2:143886909..143886922,+#_316ac51118a49930b49f7d7c5240c0fep2@ARHGAP15
1.09e-103FFCP PHASE1:Hg19::chr2:143886909..143886922,+#_316ac51118a49930b49f7d7c5240c0fep2@ARHGAP15
2.28e-103FFCP PHASE2:Hg19::chr1:202129704..202129762,-#_bcc4f6fc8980c3db98e6a711f8c875d1p1@PTPN7
2.28e-103FFCP PHASE1:Hg19::chr1:202129704..202129762,-#_bcc4f6fc8980c3db98e6a711f8c875d1p1@PTPN7
1.1e-102FFCP PHASE2:Hg19::chr1:206730484..206730499,+#_1181fbaf2b42ac7b63a2b082208444c5p2@RASSF5
1.1e-102FFCP PHASE1:Hg19::chr1:206730484..206730499,+#_1181fbaf2b42ac7b63a2b082208444c5p2@RASSF5
1.29e-102FFCP PHASE2:Hg19::chr2:143886890..143886904,+#_ec49bdfe6fd61778c38f5a37015f0b5ep4@ARHGAP15
1.29e-102FFCP PHASE1:Hg19::chr2:143886890..143886904,+#_ec49bdfe6fd61778c38f5a37015f0b5ep4@ARHGAP15
4.62e-102FFCP PHASE1:Hg19::chr10:11207485..11207496,+#_68c1ddc08c6ea22911c15d090d72882bp9@CELF2
4.62e-102FFCP PHASE2:Hg19::chr10:11207485..11207496,+#_68c1ddc08c6ea22911c15d090d72882bp9@CELF2
2.76e-101FFCP PHASE1:Hg19::chr7:45018571..45018589,-#_7a23b4422ab0720d03b44a62cd8c9429p3@MYO1G
2.76e-101FFCP PHASE2:Hg19::chr7:45018571..45018589,-#_7a23b4422ab0720d03b44a62cd8c9429p3@MYO1G
5.72e-101FFCP PHASE2:Hg19::chr19:2085323..2085357,-#_188acae3f131f3b1ccd0dc542fc1f97bp2@MOB3A
5.72e-101FFCP PHASE1:Hg19::chr19:2085323..2085357,-#_188acae3f131f3b1ccd0dc542fc1f97bp2@MOB3A
1.66e-100FFCP PHASE1:Hg19::chr1:26872324..26872362,+#_397e746d078dd8b105cb3c152991d114p1@RPS6KA1
1.66e-100FFCP PHASE2:Hg19::chr1:26872324..26872362,+#_397e746d078dd8b105cb3c152991d114p1@RPS6KA1
2.15e-100FFCP PHASE2:Hg19::chr11:73694239..73694253,-#_5a4156b8acbac7b990558cd9d3a6f87cp2@UCP2
2.15e-100FFCP PHASE1:Hg19::chr11:73694239..73694253,-#_5a4156b8acbac7b990558cd9d3a6f87cp2@UCP2
2.24e-99FFCP PHASE1:Hg19::chr12:54891496..54891526,+#_0b0c1af94b48e82d7fb268495d658ee4p2@NCKAP1L
2.24e-99FFCP PHASE2:Hg19::chr12:54891496..54891526,+#_0b0c1af94b48e82d7fb268495d658ee4p2@NCKAP1L
4.55e-99FFCP PHASE2:Hg19::chr1:161039647..161039744,-#_c9d03b292a26eb5f8c7f867d9ae2c82ap1@ARHGAP30
4.55e-99FFCP PHASE1:Hg19::chr1:161039647..161039744,-#_c9d03b292a26eb5f8c7f867d9ae2c82ap1@ARHGAP30
1.29e-98FFCP PHASE2:Hg19::chr20:34078776..34078819,-#_00c11bf05ed0f767c5f61af450366e7cp1@ENST00000453914
1.29e-98FFCP PHASE1:Hg19::chr20:34078776..34078819,-#_00c11bf05ed0f767c5f61af450366e7cp1@ENST00000453914
1.68e-98FFCP PHASE2:Hg19::chr1:206730595..206730630,+#_5ea213957be92e85c5ac902ce21119a2p3@RASSF5
1.68e-98FFCP PHASE1:Hg19::chr1:206730595..206730630,+#_5ea213957be92e85c5ac902ce21119a2p3@RASSF5
1.77e-98FFCP PHASE1:Hg19::chr19:17862274..17862335,+#_9e9659246d4e4ab3e5c27f0b600b5f9fp2@FCHO1
1.77e-98FFCP PHASE2:Hg19::chr19:17862274..17862335,+#_9e9659246d4e4ab3e5c27f0b600b5f9fp2@FCHO1
2.22e-98FFCP PHASE1:Hg19::chr17:56415424..56415454,-#_9871787b14814ab24423ec0d48714fe5p@chr17:56415424..56415454, -
2.22e-98FFCP PHASE2:Hg19::chr17:56415424..56415454,-#_9871787b14814ab24423ec0d48714fe5p@chr17:56415424..56415454, -
2.24e-98FFCP PHASE2:Hg19::chr5:169064317..169064332,+#_ea9d148d0c919a6a91f1742825c081a9p2@DOCK2
2.24e-98FFCP PHASE1:Hg19::chr5:169064317..169064332,+#_ea9d148d0c919a6a91f1742825c081a9p2@DOCK2
3.47e-98FFCP PHASE1:Hg19::chr7:45018686..45018710,-#_f785be7ecba56825664d8323231474b9p2@MYO1G
3.47e-98FFCP PHASE2:Hg19::chr7:45018686..45018710,-#_f785be7ecba56825664d8323231474b9p2@MYO1G
5.94e-98FFCP PHASE2:Hg19::chrX:128913876..128913904,+#_cc66b1465b4298adb69cb3674832fd70p2@SASH3
5.94e-98FFCP PHASE1:Hg19::chrX:128913876..128913904,+#_cc66b1465b4298adb69cb3674832fd70p2@SASH3
8.42e-98FFCP PHASE2:Hg19::chr17:56414688..56414711,+#_756853963cc471b899bcd38b001a68d8p1@uc002iwa.2, p1@uc002iwb.2, p1@uc002iwc.2
8.42e-98FFCP PHASE1:Hg19::chr17:56414688..56414711,+#_756853963cc471b899bcd38b001a68d8p1@uc002iwa.2, p1@uc002iwb.2, p1@uc002iwc.2
9.25e-98FFCP PHASE2:Hg19::chr19:14551066..14551097,+#_3229509b6c3c787b96e9b067ab18579dp2@PKN1
9.25e-98FFCP PHASE1:Hg19::chr19:14551066..14551097,+#_3229509b6c3c787b96e9b067ab18579dp2@PKN1
9.43e-98FFCP PHASE1:Hg19::chr11:64107705..64107718,+#_16db488c60291d4471b8b3d4df83a6a8p2@CCDC88B
9.43e-98FFCP PHASE2:Hg19::chr11:64107705..64107718,+#_16db488c60291d4471b8b3d4df83a6a8p2@CCDC88B
1.21e-97FFCP PHASE2:Hg19::chr1:151129103..151129130,+#_d018a92aaaaa7f53682973b91a818940p2@TNFAIP8L2
1.21e-97FFCP PHASE1:Hg19::chr1:151129103..151129130,+#_d018a92aaaaa7f53682973b91a818940p2@TNFAIP8L2
1.4e-97FFCP PHASE2:Hg19::chr2:24149046..24149063,+#_49f81dac4b507cc1191712c633734c8fp@chr2:24149046..24149063, +
1.4e-97FFCP PHASE1:Hg19::chr2:24149046..24149063,+#_49f81dac4b507cc1191712c633734c8fp@chr2:24149046..24149063, +
2.1e-97FFCP PHASE1:Hg19::chr7:50344289..50344323,+#_d2138896efb7081b13485778e50a029ap1@IKZF1
2.1e-97FFCP PHASE2:Hg19::chr7:50344289..50344323,+#_d2138896efb7081b13485778e50a029ap1@IKZF1
2.83e-97FFCP PHASE2:Hg19::chr21:15918672..15918683,-#_b3b1adc3874771a59e784c8c5e0d2c97p2@SAMSN1
2.83e-97FFCP PHASE1:Hg19::chr21:15918672..15918683,-#_b3b1adc3874771a59e784c8c5e0d2c97p2@SAMSN1
4.25e-97FFCP PHASE1:Hg19::chr7:45018602..45018625,-#_b32e08b676d46fdb9e314e56f94ffdedp1@MYO1G
4.25e-97FFCP PHASE2:Hg19::chr7:45018602..45018625,-#_b32e08b676d46fdb9e314e56f94ffdedp1@MYO1G
9.14e-97FFCP PHASE2:Hg19::chr11:67034140..67034180,+#_0b455fafe50c5ffc6601ffa0731328eep2@ADRBK1
9.14e-97FFCP PHASE1:Hg19::chr11:67034140..67034180,+#_0b455fafe50c5ffc6601ffa0731328eep2@ADRBK1
1.5e-96FFCP PHASE1:Hg19::chr22:18260077..18260127,+#_0ed38cc983a7b5f0c7ec7091aeafbb61p1@LINC00528
1.5e-96FFCP PHASE2:Hg19::chr22:18260077..18260127,+#_0ed38cc983a7b5f0c7ec7091aeafbb61p1@LINC00528
8.32e-96FFCP PHASE1:Hg19::chr1:111415786..111415804,+#_c30c4c19265d3cef6b4bdb46b8e8d92cp2@CD53
8.32e-96FFCP PHASE2:Hg19::chr1:111415786..111415804,+#_c30c4c19265d3cef6b4bdb46b8e8d92cp2@CD53
9.51e-96FFCP PHASE1:Hg19::chr19:36393354..36393363,+#_0988aa52b2ad573f026dadd751ba01d4p4@HCST
9.51e-96FFCP PHASE2:Hg19::chr19:36393354..36393363,+#_0988aa52b2ad573f026dadd751ba01d4p4@HCST
1.58e-95FFCP PHASE2:Hg19::chr1:209929388..209929412,+#_fe180a7483ff8602e5a2f1cf1a6cf4d5p3@TRAF3IP3
1.58e-95FFCP PHASE1:Hg19::chr1:209929388..209929412,+#_fe180a7483ff8602e5a2f1cf1a6cf4d5p3@TRAF3IP3
2.12e-95FFCP PHASE1:Hg19::chr9:273038..273076,+#_e6b585184a350e5243f86d05c47ff3ebp2@DOCK8
2.12e-95FFCP PHASE2:Hg19::chr9:273038..273076,+#_e6b585184a350e5243f86d05c47ff3ebp2@DOCK8
2.94e-95FFCP PHASE1:Hg19::chr19:10450328..10450351,-#_7cea8901e397446a8ae54feb77fb297cp2@ICAM3
2.94e-95FFCP PHASE2:Hg19::chr19:10450328..10450351,-#_7cea8901e397446a8ae54feb77fb297cp2@ICAM3
5.08e-95FFCP PHASE1:Hg19::chr3:151962118..151962192,+#_b785560778185bb2a2b4fd6e072eeb77p@chr3:151962118..151962192, +
5.08e-95FFCP PHASE2:Hg19::chr3:151962118..151962192,+#_b785560778185bb2a2b4fd6e072eeb77p@chr3:151962118..151962192, +
2.85e-94FFCP PHASE1:Hg19::chr16:50715172..50715194,-#_25866d0b6527903e83e112612a67f40dp2@SNX20
2.85e-94FFCP PHASE2:Hg19::chr16:50715172..50715194,-#_25866d0b6527903e83e112612a67f40dp2@SNX20
3.23e-94FFCP PHASE1:Hg19::chr19:1067256..1067270,+#_82b1b4d6d321877a13f30293ace46a19p4@HMHA1
3.23e-94FFCP PHASE2:Hg19::chr19:1067256..1067270,+#_82b1b4d6d321877a13f30293ace46a19p4@HMHA1
3.34e-94FFCP PHASE1:Hg19::chr3:196366555..196366572,+#_a7f6a4d749facacb52b73c1f11aaf782p2@LRRC33
3.34e-94FFCP PHASE2:Hg19::chr3:196366555..196366572,+#_a7f6a4d749facacb52b73c1f11aaf782p2@LRRC33
4.11e-94FFCP PHASE2:Hg19::chr19:49842010..49842054,+#_10413dccfcd153e4d4edcc0e1c0a2cdfp@chr19:49842010..49842054, +
4.11e-94FFCP PHASE1:Hg19::chr19:49842010..49842054,+#_10413dccfcd153e4d4edcc0e1c0a2cdfp@chr19:49842010..49842054, +
4.54e-94FFCP PHASE2:Hg19::chr1:31230687..31230701,-#_f9e69ef56acb49cc353b786f4bb0d871p3@LAPTM5
4.54e-94FFCP PHASE1:Hg19::chr1:31230687..31230701,-#_f9e69ef56acb49cc353b786f4bb0d871p3@LAPTM5
7.55e-94FFCP PHASE2:Hg19::chrX:30595907..30595941,-#_b463dbcfce7096664f0a785755525bafp2@CXorf21
7.55e-94FFCP PHASE1:Hg19::chrX:30595907..30595941,-#_b463dbcfce7096664f0a785755525bafp2@CXorf21
1.61e-93FFCP PHASE2:Hg19::chr12:57871853..57871879,-#_90060865916de2bcdf850b6d0dbb53e2p6@ARHGAP9
1.61e-93FFCP PHASE1:Hg19::chr12:57871853..57871879,-#_90060865916de2bcdf850b6d0dbb53e2p6@ARHGAP9
1.77e-93FFCP PHASE1:Hg19::chr6:32159579..32159592,-#_4169615468124ab9aa6ee0f1987abd00p@chr6:32159579..32159592, -
1.77e-93FFCP PHASE2:Hg19::chr6:32159579..32159592,-#_4169615468124ab9aa6ee0f1987abd00p@chr6:32159579..32159592, -
2.43e-93FFCP PHASE1:Hg19::chr1:39680895..39680915,+#_827347c85372240e5980de285ea74b6cp7@MACF1
2.43e-93FFCP PHASE2:Hg19::chr1:39680895..39680915,+#_827347c85372240e5980de285ea74b6cp7@MACF1
3.33e-93FFCP PHASE2:Hg19::chr17:56409871..56409890,-#_3c052f27475bc42f244bf2df3c5b72bbp1@AX721088
3.33e-93FFCP PHASE1:Hg19::chr17:56409871..56409890,-#_3c052f27475bc42f244bf2df3c5b72bbp1@AX721088